Impact of metformin on gastric adenocarcinoma survival: A Belgian population based study

Conclusion In the first population based study of metformin use in gastric cancer adenocarcinoma patients with previous diabetes, our findings suggest that metformin use might improve overall mortality. However, no such association was found for cancer-specific survival. Additional studies in other populations are required.
Source: Cancer Epidemiology - Category: Cancer & Oncology Source Type: research